These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

410 related items for PubMed ID: 16635348

  • 21. Number and size of lymph nodes recovered from dukes B rectal cancers: correlation with prognosis and histologic antitumor immune response.
    Murphy J, Pocard M, Jass JR, O'Sullivan GC, Lee G, Talbot IC.
    Dis Colon Rectum; 2007 Oct; 50(10):1526-34. PubMed ID: 17828403
    [Abstract] [Full Text] [Related]

  • 22. [Clinical significance of detection on lymphatic microvessel, lymphatic microvessel density and vascular endothelial growth factor-C in patients with colorectal carcinoma].
    Fan YZ, Li GM, Huang GP, Li XP.
    Zhonghua Wei Chang Wai Ke Za Zhi; 2006 Nov; 9(6):477-82. PubMed ID: 17143789
    [Abstract] [Full Text] [Related]

  • 23. Evidence for colorectal cancer micrometastases using reverse transcriptase-polymerase chain reaction analysis of MUC2 in lymph nodes.
    Bernini A, Spencer M, Frizelle S, Madoff RD, Willmott LD, McCormick SR, Niehans GA, Ho SB, Kratzke RA.
    Cancer Detect Prev; 2000 Nov; 24(1):72-9. PubMed ID: 10757125
    [Abstract] [Full Text] [Related]

  • 24. Gelatinase B expression as a prognostic factor in patients with stage II/III rectal carcinoma treated by postoperative adjuvant therapy.
    Unsal D, Akyurek N, Uner A, Erpolat OP, Han U, Akmansu M, Mentes BB, Dursun A.
    Am J Clin Oncol; 2008 Feb; 31(1):55-63. PubMed ID: 18376229
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Nm23-H1 expression does not predict clinical survival in colorectal cancer patients.
    Dusonchet L, Corsale S, Migliavacca M, Calò V, Bazan V, Amato A, Cammareri P, Totaro MS, Agnese V, Cascio S, La Rocca G, Sisto PS, Dardanoni G, Valerio MR, Grassi N, Latteri S, Cajozzo M, Buscemi M, Castorina S, Morello V, Tomasino RM, Gebbia N, Russo A.
    Oncol Rep; 2003 Feb; 10(5):1257-63. PubMed ID: 12883690
    [Abstract] [Full Text] [Related]

  • 27. Expression of nm23-H1 gene product in sarcomatous cancer cells of renal cell carcinoma: correlation with tumor stage and expression of matrix metalloproteinase-2, matrix metalloproteinase-9, sialyl Lewis X, and c-erbB-2.
    Ohba K, Miyata Y, Koga S, Kanda S, Kanetake H.
    Urology; 2005 May; 65(5):1029-34. PubMed ID: 15882758
    [Abstract] [Full Text] [Related]

  • 28. Matrix metalloproteinase/tissue inhibitors of matrix metalloproteinase phenotype identifies poor prognosis colorectal cancers.
    Curran S, Dundas SR, Buxton J, Leeman MF, Ramsay R, Murray GI.
    Clin Cancer Res; 2004 Dec 15; 10(24):8229-34. PubMed ID: 15623598
    [Abstract] [Full Text] [Related]

  • 29. Predictive value of lymph node and tumor matrix metalloproteinase expression in the analysis of metastatic periampullary tumors.
    McKenna GJ, Meneghetti A, Chen YL, Mui AL, Ong C, Scudamore CH, McMaster WR, Owen DA, Chung SW.
    J Surg Oncol; 2005 Jun 15; 90(4):239-46. PubMed ID: 15906368
    [Abstract] [Full Text] [Related]

  • 30. [Angiogenesis and the expression of nm23-H(1) tumor metastatic suppressor gene in primary breast carcinoma and their relations to lymph node metastasis].
    Li Y, Wu F, Gong W.
    Zhonghua Wai Ke Za Zhi; 2002 Mar 15; 40(3):177-9. PubMed ID: 11955409
    [Abstract] [Full Text] [Related]

  • 31. Sentinel node mapping and micrometastasis in patients with clinical stage IA non-small cell lung cancer.
    Ono T, Minamiya Y, Ito M, Saito H, Motoyama S, Nanjo H, Ogawa J.
    Interact Cardiovasc Thorac Surg; 2009 Oct 15; 9(4):659-61. PubMed ID: 19643803
    [Abstract] [Full Text] [Related]

  • 32. Topoisomerase I protein expression in primary colorectal cancer and lymph node metastases.
    Boonsong A, Curran S, McKay JA, Cassidy J, Murray GI, McLeod HL.
    Hum Pathol; 2002 Nov 15; 33(11):1114-9. PubMed ID: 12454816
    [Abstract] [Full Text] [Related]

  • 33. Correlates of urokinase-type plasminogen activator in colorectal cancer: positive relationship with nm23 and c-erbB-2 protein expression.
    Berney CR, Yang J, Fisher RJ, Russell PJ, Crowe PJ.
    Oncol Res; 1998 Nov 15; 10(1):47-54. PubMed ID: 9613457
    [Abstract] [Full Text] [Related]

  • 34. [Expression of metallothionein and FasL in colorectal cancer and its clinical significance].
    Li SY, Yu B, An P, Zuo FY, Cai HY.
    Zhonghua Wai Ke Za Zhi; 2005 Sep 01; 43(17):1118-20. PubMed ID: 16194308
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Correlation between occult neoplastic cells in the lymph node sinuses and recurrence in patients with curatively resected Dukes' B colorectal cancer.
    Mukai M, Sato S, Komatsu N, Nishida T, Shiba K, Ito I, Nakasaki H, Makuuchi H.
    Oncol Rep; 2003 Sep 01; 10(5):1177-81. PubMed ID: 12883677
    [Abstract] [Full Text] [Related]

  • 37. The prognostic significance of immunohistochemically detected lymph node micrometastases in colorectal carcinoma.
    Jeffers MD, O'Dowd GM, Mulcahy H, Stagg M, O'Donoghue DP, Toner M.
    J Pathol; 1994 Feb 01; 172(2):183-7. PubMed ID: 7513353
    [Abstract] [Full Text] [Related]

  • 38. Allelic imbalance at NME1 in microdissected primary and metastatic human colorectal carcinomas is frequent but not associated with metastasis to lymph nodes or liver.
    Lamb RF, Going JJ, Pickford I, Birnie GD.
    Cancer Res; 1996 Feb 15; 56(4):916-20. PubMed ID: 8631033
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Selection criteria for high risk and low risk groups of recurrence and metastasis in patients with primary colorectal cancer.
    Mukai M, Sato S, Nishida T, Komatsu N, Shiba K, Nakasaki H, Makuuchi H.
    Oncol Rep; 2003 Feb 15; 10(6):1753-8. PubMed ID: 14534691
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.